Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

O'Donovan, Michael Conlon ORCID: https://orcid.org/0000-0001-7073-2379, Norton, Nadine ORCID: https://orcid.org/0000-0002-3848-4288, Williams, Hywel John ORCID: https://orcid.org/0000-0001-7758-0312, Peirce, Timothy Rowan, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483, Nikolov, Ivan, Hamshere, Marian Lindsay ORCID: https://orcid.org/0000-0002-8990-0958, Carroll, Liam Stuart, Georgieva, Lyudmila, Dwyer, Sarah Lynne, Holmans, Peter Alan ORCID: https://orcid.org/0000-0003-0870-9412, Marchini, J. L., Spencer, C. C. A., Howie, B., Leung, H.T., Giegling, I., Hartmann, A. M., Möller, H.J., Morris, D. W., Shi, Y., Feng, G., Hoffmann, P., Propping, P., Vasilescu, C., Maier, W., Rietschel, M., Zammit, Stanley ORCID: https://orcid.org/0000-0002-2647-9211, Schumacher, J., Quinn, E. M., Schulze, T. G., Iwata, N., Ikeda, M., Darvasi, A., Shifman, S., He, L., Duan, J., Sanders, A. R., Levinson, D. F., Adolfsson, R., Ösby, U., Terenius, L, Jönsson, E. G., Cichon, S., Nöthen, M. M., Gill, M., Corvin, A. P., Rujescu, D., Gejman, P. V., Kirov, George ORCID: https://orcid.org/0000-0002-3427-3950, Craddock, Nicholas John ORCID: https://orcid.org/0000-0003-2171-0610, Williams, Nigel Melville ORCID: https://orcid.org/0000-0003-1177-6931 and Owen, Michael John ORCID: https://orcid.org/0000-0003-4798-0862 2009. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Molecular Psychiatry 14 (1) , pp. 30-36. 10.1038/mp.2008.108

Full text not available from this repository.

Abstract

We and others have previously reported linkage to schizophrenia on chromosome 10q25–q26 but, to date, a susceptibility gene in the region has not been identified. We examined data from 3606 single-nucleotide polymorphisms (SNPs) mapping to 10q25–q26 that had been typed in a genome-wide association study (GWAS) of schizophrenia (479 UK cases/2937 controls). SNPs with P<0.01 (n=40) were genotyped in an additional 163 UK cases and those markers that remained nominally significant at P<0.01 (n=22) were genotyped in replication samples from Ireland, Germany and Bulgaria consisting of a total of 1664 cases with schizophrenia and 3541 controls. Only one SNP, rs17101921, was nominally significant after meta-analyses across the replication samples and this was genotyped in an additional six samples from the United States/Australia, Germany, China, Japan, Israel and Sweden (n=5142 cases/6561 controls). Across all replication samples, the allele at rs17101921 that was associated in the GWAS showed evidence for association independent of the original data (OR 1.17 (95% CI 1.06–1.29), P=0.0009). The SNP maps 85 kb from the nearest gene encoding fibroblast growth factor receptor 2 (FGFR2) making this a potential susceptibility gene for schizophrenia.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Neuroscience and Mental Health Research Institute (NMHRI) Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Systems Immunity Research Institute (SIURI)
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords:	FGFR2; schizophrenia; genome-wide association study FGFR2; schizophrenia; genome-wide association study
Publisher:	Nature Publishing Group
ISSN:	1359-4184
Last Modified:	06 Nov 2022 13:42
URI:	https://orca.cardiff.ac.uk/id/eprint/27689

Citation Data

Cited 57 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item